Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases (IDEAL-PM)
Development of an IDEAL Framework to Standardise the Complex Intervention of Cytoreductive Surgery for Colorectal Peritoneal Metastases: a Necessary Step to Phase III Trials
Sponsor: Bowel Disease Research Foundation (BDRF)
Listed as NCT03733184, this observational or N/A phase trial focuses on Colorectal Cancer Metastatic and Peritoneal Metastases and remains completed. Sponsored by Bowel Disease Research Foundation (BDRF), it has been updated 7 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Oct 2021 — Dec 2023 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting
▶ Show 2 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting
-
Dec 2018 — Nov 2019 [monthly]
Active Not Recruiting
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bowel Disease Research Foundation (BDRF)
- Hampshire Hospitals NHS Foundation Trust
- The Christie NHS Foundation Trust
- University Hospital Birmingham
- University of Manchester
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.